2020
DOI: 10.1002/rmb2.12320
|View full text |Cite
|
Sign up to set email alerts
|

Equivalent clinical outcome after vitrified‐thawed blastocyst transfer using semi‐automated embryo vitrification system compared with manual vitrification method

Abstract: Purpose This study compared Gavi®, an automated system for the equilibration and dehydration steps of vitrification, and a manual vitrification procedure in terms of effects on clinical outcomes. Methods The authors retrospectively compared survival rate, and clinical and perinatal outcomes after vitrified‐thawed single blastocyst transfer between Gavi® (G method) in 398 cases and Cryotop® (C method) in 208 cases. Results With C and G methods, survival rates were 98.6% (208/211) and 99.3% (398/401), total preg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 21 publications
(34 reference statements)
0
8
0
Order By: Relevance
“…Recently, a retrospective study on human embryos compared survival rate and clinical and perinatal outcomes after vitrification and worming of single blastocysts with Gavi (398 cases) or with the Cryotop method (Kitazato Corporation; 208 cases). Gavi showed comparable clinical outcomes to the manual vitrification method resulting as an alternative vitrification procedure in IVF (103).…”
Section: Vitrificationmentioning
confidence: 87%
“…Recently, a retrospective study on human embryos compared survival rate and clinical and perinatal outcomes after vitrification and worming of single blastocysts with Gavi (398 cases) or with the Cryotop method (Kitazato Corporation; 208 cases). Gavi showed comparable clinical outcomes to the manual vitrification method resulting as an alternative vitrification procedure in IVF (103).…”
Section: Vitrificationmentioning
confidence: 87%
“…The first automated cryopreservation (vitrification) device, Gavi® (Genea Biomedx, Australia), showed equivalent clinical efficiency in embryo survival post-embryo thaw when compared to existing manual methods [86]. The automated equilibration of embryos prior to vitrification offers reduced labour intensity and improved accuracy with the maintenance of optimal conditions such as embryo positioning, cryoprotectant concentration, exposure time, cooling rates, volume, and temperature [87].…”
Section: Cryopreservation and Cryostoragementioning
confidence: 99%
“…At the same time, making each act of vitrification is traceable. Assessment of the efficiency of the semi-automated platform as compared with the reference method (manual) was recently made at the zygote [ 22 ], cleaved embryo [ 20 ] or blastocyst stages [ 29 ]. However, there is no comparative study on the expected oocyte survival rate using the Gavi® system.…”
Section: Introductionmentioning
confidence: 99%